Compare SMTC & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTC | COO |
|---|---|---|
| Founded | 1960 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 15.0B |
| IPO Year | 2002 | 1994 |
| Metric | SMTC | COO |
|---|---|---|
| Price | $131.60 | $71.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $93.20 | $90.18 |
| AVG Volume (30 Days) | ★ 2.9M | 1.6M |
| Earning Date | 05-26-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.65 | N/A |
| EPS | 0.27 | 0.27 |
| Revenue | $1,049,975,000.00 | ★ $2,532,800,000.00 |
| Revenue This Year | $20.10 | $6.66 |
| Revenue Next Year | $13.01 | $5.18 |
| P/E Ratio | $527.52 | ★ $262.81 |
| Revenue Growth | 15.47 | ★ 18.41 |
| 52 Week Low | $55.18 | $58.89 |
| 52 Week High | $177.35 | $89.83 |
| Indicator | SMTC | COO |
|---|---|---|
| Relative Strength Index (RSI) | 53.17 | 38.34 |
| Support Level | $70.37 | $68.89 |
| Resistance Level | $149.17 | $73.04 |
| Average True Range (ATR) | 9.45 | 1.29 |
| MACD | 1.17 | -0.79 |
| Stochastic Oscillator | 57.76 | 4.19 |
Semtech Corp is a provider of high-performance semiconductors powering data center networking, Internet of Things ("IoT") connectivity, and cellular infrastructure solutions. The company designs, develops, manufactures, and markets a diverse portfolio of products for commercial applications, addressing the infrastructure, high-end consumer, and industrial end markets. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems, and Connected Services. The majority of the company's revenue is earned through the Analog Mixed Signal and Wireless segment. Geographically, the majority of the company's revenue is earned from the Asia Pacific region; the company also operates in North America and Europe.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.